Marshall Wace North America’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-125,114
| Closed | -$2.36M | – | 1761 |
|
2019
Q3 | $2.36M | Buy |
+125,114
| New | +$2.36M | 0.01% | 515 |
|
2017
Q4 | – | Sell |
-81,681
| Closed | -$980K | – | 1742 |
|
2017
Q3 | $980K | Buy |
+81,681
| New | +$980K | 0.01% | 955 |
|
2017
Q2 | – | Sell |
-211,913
| Closed | -$4.45M | – | 1527 |
|
2017
Q1 | $4.45M | Buy |
+211,913
| New | +$4.45M | 0.04% | 420 |
|